178 related articles for article (PubMed ID: 10084635)
1. Nefazodone in social phobia.
Van Ameringen M; Mancini C; Oakman JM
J Clin Psychiatry; 1999 Feb; 60(2):96-100. PubMed ID: 10084635
[TBL] [Abstract][Full Text] [Related]
2. Paroxetine in social phobia.
Mancini C; Ameringen MV
J Clin Psychiatry; 1996 Nov; 57(11):519-22. PubMed ID: 8968300
[TBL] [Abstract][Full Text] [Related]
3. Nefazodone for social phobia: a clinical case series.
Worthington JJ; Zucker BG; Fones CS; Otto MW; Pollack MH
Depress Anxiety; 1998; 8(3):131-3. PubMed ID: 9836065
[TBL] [Abstract][Full Text] [Related]
4. Nefazodone in the treatment of generalized social phobia: a randomized, placebo-controlled trial.
Van Ameringen M; Mancini C; Oakman J; Walker J; Kjernisted K; Chokka P; Johnston D; Bennett M; Patterson B
J Clin Psychiatry; 2007 Feb; 68(2):288-95. PubMed ID: 17335328
[TBL] [Abstract][Full Text] [Related]
5. Fluoxetine efficacy in social phobia.
Van Ameringen M; Mancini C; Streiner DL
J Clin Psychiatry; 1993 Jan; 54(1):27-32. PubMed ID: 8428894
[TBL] [Abstract][Full Text] [Related]
6. An open-label trial of nefazodone in high comorbidity panic disorder.
DeMartinis NA; Schweizer E; Rickels K
J Clin Psychiatry; 1996 Jun; 57(6):245-8. PubMed ID: 8666561
[TBL] [Abstract][Full Text] [Related]
7. An open trial of topiramate in the treatment of generalized social phobia.
Van Ameringen M; Mancini C; Pipe B; Oakman J; Bennett M
J Clin Psychiatry; 2004 Dec; 65(12):1674-8. PubMed ID: 15641873
[TBL] [Abstract][Full Text] [Related]
8. Symptomatic and syndromal anxiety in chronic forms of major depression: effect of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination.
Ninan PT; Rush AJ; Crits-Christoph P; Kornstein SG; Manber R; Thase ME; Trivedi MH; Rothbaum BO; Zajecka J; Borian FE; Keller MB
J Clin Psychiatry; 2002 May; 63(5):434-41. PubMed ID: 12025827
[TBL] [Abstract][Full Text] [Related]
9. Open trial of nefazodone for combat-related posttraumatic stress disorder.
Hertzberg MA; Feldman ME; Beckham JC; Moore SD; Davidson JR
J Clin Psychiatry; 1998 Sep; 59(9):460-4. PubMed ID: 9771816
[TBL] [Abstract][Full Text] [Related]
10. Serotonergic agents in the treatment of social phobia in children and adolescents: a case series.
Mancini C; Van Ameringen M; Oakman JM; Farvolden P
Depress Anxiety; 1999; 10(1):33-9. PubMed ID: 10499188
[TBL] [Abstract][Full Text] [Related]
11. Nefazodone in patients with treatment-refractory posttraumatic stress disorder.
Zisook S; Chentsova-Dutton YE; Smith-Vaniz A; Kline NA; Ellenor GL; Kodsi AB; Gillin JC
J Clin Psychiatry; 2000 Mar; 61(3):203-8. PubMed ID: 10817106
[TBL] [Abstract][Full Text] [Related]
12. The Kutcher Generalized Social Anxiety Disorder Scale for Adolescents: assessment of its evaluative properties over the course of a 16-week pediatric psychopharmacotherapy trial.
Brooks SJ; Kutcher S
J Child Adolesc Psychopharmacol; 2004; 14(2):273-86. PubMed ID: 15319024
[TBL] [Abstract][Full Text] [Related]
13. Open trial of nefazodone for combat veterans with posttraumatic stress disorder.
Garfield DA; Fichtner CG; Leveroni C; Mahableshwarkar A
J Trauma Stress; 2001 Jul; 14(3):453-60. PubMed ID: 11534877
[TBL] [Abstract][Full Text] [Related]
14. Bupropion-SR in treatment of social phobia.
Emmanuel NP; Brawman-Mintzer O; Morton WA; Book SW; Johnson MR; Lorberbaum JP; Ballenger JC; Lydiard RB
Depress Anxiety; 2000; 12(2):111-3. PubMed ID: 11091936
[TBL] [Abstract][Full Text] [Related]
15. [Short-term effects of a cognitive-behavioural group therapy in social phobia: evaluation of sixty patients].
Camart N; André C; Trybou V; Bourdel MC
Encephale; 2006; 32(6 Pt 1):1011-8. PubMed ID: 17372547
[TBL] [Abstract][Full Text] [Related]
16. A double-blind, placebo-controlled trial of nefazodone in the treatment of patients hospitalized for major depression.
Feighner J; Targum SD; Bennett ME; Roberts DL; Kensler TT; D'Amico MF; Hardy SA
J Clin Psychiatry; 1998 May; 59(5):246-53. PubMed ID: 9632036
[TBL] [Abstract][Full Text] [Related]
17. Buspirone in social phobia.
Schneier FR; Saoud JB; Campeas R; Fallon BA; Hollander E; Coplan J; Liebowitz MR
J Clin Psychopharmacol; 1993 Aug; 13(4):251-6. PubMed ID: 8376612
[TBL] [Abstract][Full Text] [Related]
18. Fluvoxamine treatment of social phobia (social anxiety disorder): a double-blind, placebo-controlled study.
Stein MB; Fyer AJ; Davidson JR; Pollack MH; Wiita B
Am J Psychiatry; 1999 May; 156(5):756-60. PubMed ID: 10327910
[TBL] [Abstract][Full Text] [Related]
19. An open-label study of nefazodone treatment of major depression in patients with congestive heart failure.
Lespérance F; Frasure-Smith N; Laliberté MA; White M; Lafontaine S; Calderone A; Talajic M; Rouleau JL
Can J Psychiatry; 2003 Nov; 48(10):695-701. PubMed ID: 14674053
[TBL] [Abstract][Full Text] [Related]
20. [Validation of a scale for responsibility (Salkovskis Responsibility Scale)].
Bouvard M; Robbe-Grillet P; Milliery M; Pham S; Amireche S; Fanget F; Guerin J; Cottraux J
Encephale; 2001; 27(3):229-37. PubMed ID: 11488253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
